TY - JOUR AU - Suker, M. AU - Beumer, B. R. AU - Sadot, E. AU - Marthey, L. AU - Faris, J. E. AU - Mellon, E. A. PY - 2016 DA - 2016// TI - FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis JO - Lancet Oncol VL - 17 UR - https://doi.org/10.1016/S1470-2045(16)00172-8 DO - 10.1016/S1470-2045(16)00172-8 ID - Suker2016 ER - TY - JOUR AU - Iacobuzio-Donahue, C. A. AU - Fu, B. AU - Yachida, S. AU - Luo, M. AU - Abe, H. AU - Henderson, C. M. PY - 2009 DA - 2009// TI - DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2008.17.7188 DO - 10.1200/JCO.2008.17.7188 ID - Iacobuzio-Donahue2009 ER - TY - JOUR AU - Crane, C. h. r. i. s. t. o. p. h. e. r. H. AU - Varadhachary, G. a. u. r. i. R. AU - Yordy, J. o. h. n. S. AU - Staerkel, G. r. e. g. g. A. AU - Javle, M. i. l. i. n. d. M. AU - Safran, H. o. w. a. r. d. AU - Haque, W. a. q. a. r. AU - Hobbs, B. r. i. d. g. e. t. t. D. AU - Krishnan, S. u. n. i. l. AU - Fleming, J. a. s. o. n. B. AU - Das, P. r. a. j. n. a. n. AU - Lee, J. e. f. f. r. e. y. E. AU - Abbruzzese, J. a. m. e. s. L. AU - Wolff, R. o. b. e. r. t. A. PY - 2011 DA - 2011// TI - Phase II Trial of Cetuximab, Gemcitabine, and Oxaliplatin Followed by Chemoradiation With Cetuximab for Locally Advanced (T4) Pancreatic Adenocarcinoma: Correlation ofSmad4(Dpc4)Immunostaining With Pattern of Disease Progression JO - Journal of Clinical Oncology VL - 29 UR - https://doi.org/10.1200/JCO.2010.33.8038 DO - 10.1200/JCO.2010.33.8038 ID - Crane2011 ER - TY - JOUR PY - 1988 DA - 1988// TI - Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone JO - J Natl Cancer Inst VL - 80 UR - https://doi.org/10.1093/jnci/80.10.751 DO - 10.1093/jnci/80.10.751 ID - ref4 ER - TY - JOUR AU - Chauffert, B. AU - Mornex, F. AU - Bonnetain, F. AU - Rougier, P. AU - Mariette, C. AU - Bouche, O. PY - 2008 DA - 2008// TI - Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study JO - Ann Oncol VL - 19 UR - https://doi.org/10.1093/annonc/mdn281 DO - 10.1093/annonc/mdn281 ID - Chauffert2008 ER - TY - JOUR AU - Klaassen, D. J. AU - MacIntyre, J. M. AU - Catton, G. E. PY - 1985 DA - 1985// TI - Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil-an eastern cooperative oncology group study JO - J Clin Oncol VL - 3 UR - https://doi.org/10.1200/JCO.1985.3.3.373 DO - 10.1200/JCO.1985.3.3.373 ID - Klaassen1985 ER - TY - JOUR AU - Hammel, P. AU - Huguet, F. AU - Laethem, J. L. AU - Goldstein, D. AU - Glimelius, B. AU - Artru, P. PY - 2016 DA - 2016// TI - Effect of Chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without Erlotinib: the LAP07 randomized clinical trial JO - JAMA VL - 315 UR - https://doi.org/10.1001/jama.2016.4324 DO - 10.1001/jama.2016.4324 ID - Hammel2016 ER - TY - JOUR AU - Loehrer, P. J. AU - Feng, Y. AU - Cardenes, H. AU - Wagner, L. AU - Brell, J. M. AU - Cella, D. PY - 2011 DA - 2011// TI - Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial JO - J Clin Oncol VL - 29 UR - https://doi.org/10.1200/JCO.2011.34.8904 DO - 10.1200/JCO.2011.34.8904 ID - Loehrer2011 ER - TY - JOUR AU - Conroy, T. AU - Desseigne, F. AU - Ychou, M. AU - Bouche, O. AU - Guimbaud, R. AU - Becouarn, Y. PY - 2011 DA - 2011// TI - FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer JO - N Engl J Med VL - 364 UR - https://doi.org/10.1056/NEJMoa1011923 DO - 10.1056/NEJMoa1011923 ID - Conroy2011 ER - TY - JOUR AU - Hoff, D. D. AU - Ervin, T. AU - Arena, F. P. AU - Chiorean, E. G. AU - Infante, J. AU - Moore, M. PY - 2013 DA - 2013// TI - Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine JO - N Engl J Med VL - 369 UR - https://doi.org/10.1056/NEJMoa1304369 DO - 10.1056/NEJMoa1304369 ID - Hoff2013 ER - TY - JOUR AU - Schellenberg, D. AU - Goodman, K. A. AU - Lee, F. AU - Chang, S. AU - Kuo, T. AU - Ford, J. M. PY - 2008 DA - 2008// TI - Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer JO - Int J Radiat Oncol Biol Phys VL - 72 UR - https://doi.org/10.1016/j.ijrobp.2008.01.051 DO - 10.1016/j.ijrobp.2008.01.051 ID - Schellenberg2008 ER - TY - JOUR AU - Hoyer, M. AU - Roed, H. AU - Sengelov, L. AU - Traberg, A. AU - Ohlhuis, L. AU - Pedersen, J. PY - 2005 DA - 2005// TI - Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma JO - Radiother Oncol VL - 76 UR - https://doi.org/10.1016/j.radonc.2004.12.022 DO - 10.1016/j.radonc.2004.12.022 ID - Hoyer2005 ER - TY - JOUR AU - Herman, J. M. AU - Chang, D. T. AU - Goodman, K. A. AU - Dholakia, A. S. AU - Raman, S. P. AU - Hacker-Prietz, A. PY - 2015 DA - 2015// TI - Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma JO - Cancer VL - 121 UR - https://doi.org/10.1002/cncr.29161 DO - 10.1002/cncr.29161 ID - Herman2015 ER - TY - JOUR AU - Park, J. J. AU - Hajj, C. AU - Reyngold, M. AU - Shi, W. AU - Zhang, Z. AU - Cuaron, J. J. PY - 2017 DA - 2017// TI - Stereotactic body radiation vs. intensity-modulated radiation for unresectable pancreatic cancer JO - Acta Oncol VL - 56 UR - https://doi.org/10.1080/0284186X.2017.1342863 DO - 10.1080/0284186X.2017.1342863 ID - Park2017 ER - TY - JOUR AU - Zhong, J. AU - Patel, K. AU - Switchenko, J. AU - Cassidy, R. J. AU - Hall, W. A. AU - Gillespie, T. PY - 2017 DA - 2017// TI - Outcomes for patients with locally advanced pancreatic adenocarcinoma treated with stereotactic body radiation therapy versus conventionally fractionated radiation JO - Cancer VL - 123 UR - https://doi.org/10.1002/cncr.30706 DO - 10.1002/cncr.30706 ID - Zhong2017 ER - TY - JOUR AU - Krishnan, S. u. n. i. l. AU - Chadha, A. w. a. l. p. r. e. e. t. S. AU - Suh, Y. e. l. i. n. AU - Chen, H. s. i. a. n. g. -. C. h. u. n. AU - Rao, A. r. v. i. n. d. AU - Das, P. r. a. j. n. a. n. AU - Minsky, B. r. u. c. e. D. AU - Mahmood, U. s. a. m. a. AU - Delclos, M. a. r. c. E. AU - Sawakuchi, G. a. b. r. i. e. l. O. AU - Beddar, S. a. m. AU - Katz, M. a. t. t. h. e. w. H. AU - Fleming, J. a. s. o. n. B. AU - Javle, M. i. l. i. n. d. M. AU - Varadhachary, G. a. u. r. i. R. AU - Wolff, R. o. b. e. r. t. A. AU - Crane, C. h. r. i. s. t. o. p. h. e. r. H. PY - 2016 DA - 2016// TI - Focal Radiation Therapy Dose Escalation Improves Overall Survival in Locally Advanced Pancreatic Cancer Patients Receiving Induction Chemotherapy and Consolidative Chemoradiation JO - International Journal of Radiation Oncology*Biology*Physics VL - 94 UR - https://doi.org/10.1016/j.ijrobp.2015.12.003 DO - 10.1016/j.ijrobp.2015.12.003 ID - Krishnan2016 ER - TY - JOUR AU - Bohoudi, O. AU - Bruynzeel, A. M. E. AU - Senan, S. AU - Cuijpers, J. P. AU - Slotman, B. J. AU - Lagerwaard, F. J. PY - 2017 DA - 2017// TI - Fast and robust online adaptive planning in stereotactic MR-guided adaptive radiation therapy (SMART) for pancreatic cancer JO - Radiother Oncol VL - 125 UR - https://doi.org/10.1016/j.radonc.2017.07.028 DO - 10.1016/j.radonc.2017.07.028 ID - Bohoudi2017 ER - TY - JOUR AU - Henke, L. AU - Kashani, R. AU - Robinson, C. AU - Curcuru, A. AU - DeWees, T. AU - Bradley, J. PY - 2018 DA - 2018// TI - Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen JO - Radiother Oncol VL - 126 UR - https://doi.org/10.1016/j.radonc.2017.11.032 DO - 10.1016/j.radonc.2017.11.032 ID - Henke2018 ER - TY - JOUR AU - Rudra, S. AU - Jiang, N. AU - Rosenberg, S. A. AU - Olsen, J. R. AU - Parikh, P. J. AU - Bassetti, M. F. PY - 2017 DA - 2017// TI - High dose adaptive MRI guided radiation therapy improves overall survival of inoperable pancreatic cancer JO - Int J Radiat Oncol Biol Phys VL - 99 UR - https://doi.org/10.1016/j.ijrobp.2017.06.1042 DO - 10.1016/j.ijrobp.2017.06.1042 ID - Rudra2017 ER - TY - JOUR AU - Kelly, P. AU - Das, P. AU - Pinnix, C. C. AU - Beddar, S. AU - Briere, T. AU - Pham, M. PY - 2013 DA - 2013// TI - Duodenal toxicity after fractionated chemoradiation for unresectable pancreatic cancer JO - Int J Radiat Oncol Biol Phys VL - 85 UR - https://doi.org/10.1016/j.ijrobp.2012.09.035 DO - 10.1016/j.ijrobp.2012.09.035 ID - Kelly2013 ER -